Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1
Andre Costa-Pozza (Dublin, Ireland), Jim J. Egan, Daniela Gompelmann, Pallav L. Shah, Christian Grah, Arschang Valipour, Joachim H. Ficker, Manfred Wagner, Christian Witt, Uta Liebers, Peter Hopkins, Wolfgang Gesierich, Martin Phillips, Franz Stanzel, William H. McNulty, Christoph Petermann, Greg Snell, Ralf Eberhardt, Felix J.F. Herth, Andre Costa-Pozza
Source: International Congress 2016 – Endoscopic lung volume reduction II
Session: Endoscopic lung volume reduction II
Session type: Poster Discussion
Number: 1850
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Andre Costa-Pozza (Dublin, Ireland), Jim J. Egan, Daniela Gompelmann, Pallav L. Shah, Christian Grah, Arschang Valipour, Joachim H. Ficker, Manfred Wagner, Christian Witt, Uta Liebers, Peter Hopkins, Wolfgang Gesierich, Martin Phillips, Franz Stanzel, William H. McNulty, Christoph Petermann, Greg Snell, Ralf Eberhardt, Felix J.F. Herth, Andre Costa-Pozza. Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1. Eur Respir J 2016; 48: Suppl. 60, 1850
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: